{"count":11,"next":null,"previous":null,"results":[{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Expert list"],"phenotypes":["Malignant Melanoma"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","tags":[],"panel":{"id":133,"hash_id":"596f89168f620352d1224bdb","name":"Melanoma pertinent cancer susceptibility","disease_group":"Cancer Programme","disease_sub_group":"Pertinent cancer susceptibility gene panel","status":"public","version":"1.0","version_created":"2017-11-05T02:37:20.089397Z","relevant_disorders":["Malignant Melanoma"],"stats":{"number_of_genes":3,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Cancer Germline 100K","slug":"cancer-germline-100k","description":"Cancer Germline 100K"}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":null,"publications":[],"evidence":["Expert list","Expert Review Green"],"phenotypes":["Familial Malignant Melanoma and Tumors of the Nervous system, Familial Uveal Melanoma"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":391,"hash_id":null,"name":"Adult solid tumours for rare disease","disease_group":"Tumour syndromes","disease_sub_group":"Tumour syndromes","status":"public","version":"1.22","version_created":"2019-06-20T15:10:02.142139Z","relevant_disorders":["Young adult onset cancer","Exceptionally young adult onset cancer","Multiple Tumours","Rare tumour predisposition syndromes"],"stats":{"number_of_genes":58,"number_of_strs":0,"number_of_regions":1},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Emory Genetics Laboratory"],"phenotypes":["Gastrointestinal and Colorectal Cancer"],"mode_of_inheritance":"","tags":[],"panel":{"id":254,"hash_id":"591444928f620348d4b20c16","name":"GI tract tumours","disease_group":"Tumour syndromes","disease_sub_group":"GI tract","status":"public","version":"1.18","version_created":"2019-08-05T14:17:21.117330Z","relevant_disorders":["GI tract tumours","Familial colon cancer","Multiple bowel polyps","Peutz-Jeghers syndrome","GI tract","Inherited colorectal cancer (with or without polyposis)"],"stats":{"number_of_genes":30,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Adult solid tumours for rare disease (Version 1.21)"],"phenotypes":["Familial Malignant Melanoma and Tumors of the Nervous system, Familial Uveal Melanoma"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":470,"hash_id":null,"name":"Tumour predisposition - adult onset","disease_group":"","disease_sub_group":"","status":"public","version":"1.1","version_created":"2019-06-20T15:14:23.703488Z","relevant_disorders":[],"stats":{"number_of_genes":63,"number_of_strs":0,"number_of_regions":2},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","NHS GMS","Expert List"],"phenotypes":[],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":522,"hash_id":null,"name":"Familial melanoma","disease_group":"","disease_sub_group":"","status":"public","version":"1.0","version_created":"2019-08-16T10:02:44.576997Z","relevant_disorders":["R254"],"stats":{"number_of_genes":8,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"GMS signed-off","slug":"gms-signed-off","description":"This panel has undergone review by a NHSE GMS disease specialist group and processes to be signed-off for use within the GMS."}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","NHS GMS","Expert List"],"phenotypes":[],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":524,"hash_id":null,"name":"Inherited pancreatic cancer","disease_group":"","disease_sub_group":"","status":"public","version":"0.30","version_created":"2019-09-24T14:03:08.035831Z","relevant_disorders":["R367"],"stats":{"number_of_genes":11,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["London North GLH","NHS GMS","Expert Review Green"],"phenotypes":["Melanoma susceptibility"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","tags":[],"panel":{"id":559,"hash_id":null,"name":"Pigmentary skin disorders","disease_group":"","disease_sub_group":"","status":"public","version":"0.15","version_created":"2019-09-17T17:51:23.014209Z","relevant_disorders":[],"stats":{"number_of_genes":102,"number_of_strs":0,"number_of_regions":1},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","UKGTN"],"phenotypes":[],"mode_of_inheritance":"","tags":[],"panel":{"id":230,"hash_id":"553f979fbb5a1616e5ed45f8","name":"Cataracts","disease_group":"Ophthalmological disorders","disease_sub_group":"Anterior segment abnormalities","status":"public","version":"2.0","version_created":"2019-10-02T14:52:22.701027Z","relevant_disorders":["R31"],"stats":{"number_of_genes":172,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"GMS signed-off","slug":"gms-signed-off","description":"This panel has undergone review by a NHSE GMS disease specialist group and processes to be signed-off for use within the GMS."}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":["27960642","27756164"],"evidence":["Expert Review Red","BRIDGE consortium (NIHRBR-RD)"],"phenotypes":["Acute lymphoblastic leukemia (ALL)"],"mode_of_inheritance":"Other - please specifiy in evaluation comments","tags":["somatic"],"panel":{"id":159,"hash_id":"58a70e858f62037e8779b2e8","name":"Cytopenias and congenital anaemias","disease_group":"Haematological disorders","disease_sub_group":"Anaemias and red cell disorders","status":"public","version":"1.73","version_created":"2019-09-23T11:25:32.403071Z","relevant_disorders":["Aplastic anaemia with or without paroxysmal nocturnal haemoglobinuria","Apparent aplastic anaemia or paroxysmal nocturnal haemoglobinuria","Congenital anaemias","Early onset pancytopenia and red cell disorders","Anaemias and red cell disorders","Cytopaenias and congenital anaemias","Cytopenia and pancytopenia"],"stats":{"number_of_genes":219,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"0","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Removed","London North GLH","NHS GMS"],"phenotypes":["Melanoma susceptibility"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","tags":[],"panel":{"id":558,"hash_id":null,"name":"Multiple monogenic benign skin tumours","disease_group":"","disease_sub_group":"","status":"public","version":"0.10","version_created":"2019-06-20T15:15:13.746402Z","relevant_disorders":[],"stats":{"number_of_genes":43,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["CDK4I","p16","INK4a","MTS1","CMM2","ARF","p19","p14","INK4","p16INK4a","p19Arf","p14ARF"],"biotype":"protein_coding","hgnc_id":"HGNC:1787","gene_name":"cyclin dependent kinase inhibitor 2A","omim_gene":["600160"],"alias_name":null,"gene_symbol":"CDKN2A","hgnc_symbol":"CDKN2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"9:21967751-21995300","ensembl_id":"ENSG00000147889"}},"GRch38":{"90":{"location":"9:21967753-21995301","ensembl_id":"ENSG00000147889"}}},"hgnc_date_symbol_changed":"1994-05-19"},"entity_type":"gene","entity_name":"CDKN2A","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["NHS GMS","Expert Review Green","Expert list"],"phenotypes":["Familial Malignant Melanoma and Tumors of the Nervous system, Familial Uveal Melanoma"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown","tags":[],"panel":{"id":245,"hash_id":"595ce30f8f62036352471f39","name":"Adult solid tumours cancer susceptibility","disease_group":"Cancer Programme","disease_sub_group":"Pertinent cancer susceptibility gene panel","status":"public","version":"1.7","version_created":"2019-08-13T09:55:08.772098Z","relevant_disorders":["Carcinoma of unknown primary","Other","Adult solid tumours pertinent cancer susceptibility"],"stats":{"number_of_genes":103,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Cancer Germline 100K","slug":"cancer-germline-100k","description":"Cancer Germline 100K"},{"name":"GMS Cancer Germline Virtual","slug":"gms-cancer-germline-virtual","description":"This is a panel used for WGS germline analysis for the GMS."}]}}]}